中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [45]
上海生物化学与细胞生... [5]
上海营养与健康研究所 [5]
合肥物质科学研究院 [3]
昆明动物研究所 [3]
生物物理研究所 [2]
更多
采集方式
OAI收割 [73]
iSwitch采集 [2]
内容类型
期刊论文 [71]
会议论文 [3]
学位论文 [1]
发表日期
2025 [4]
2024 [1]
2023 [3]
2022 [3]
2021 [7]
2020 [2]
更多
学科主题
Biochemist... [3]
Cell Biolo... [3]
Research &... [2]
Science & ... [2]
Biochemist... [1]
Biochemist... [1]
更多
筛选
浏览/检索结果:
共75条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
HDAC inhibitor GCJ-490A modulates tumor microenvironment and synergizes with PD-1 antibody against breast and lung cancers in syngeneic murine models
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2025, 页码: 13
作者:
Zhang, Wen-xin
;
He, Ting
;
Fang, Kun
;
Gao, Ying-lei
;
Sun, Yi-ming
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2025/12/04
HDAC inhibitor
GCJ-490A
tumor microenvironment
PD-1 antibody
CXCL7
Mechanism of hydroxamic acid group metabolism to carboxylic acid: Oxidation versus hydrolysis
期刊论文
OAI收割
DRUG METABOLISM AND DISPOSITION, 2025, 卷号: 53, 期号: 10, 页码: 11
作者:
Huang, Xiyue
;
Zhou, Lei
;
Chen, Huixian
;
Sun, Xiaowei
;
Cao, Mengyi
  |  
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2025/12/04
Hydroxamic acid group
Bisthianostat
HDAC inhibitor
Cytochrome P450 enzymes
Oxidative cleavage
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2025, 卷号: 15, 期号: 3, 页码: 1659-1679
作者:
Jin, Yuheng
;
Qi, Xuxin
;
Yu, Xiaoli
;
Cheng, Xirui
;
Chen, Boya
  |  
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2025/06/23
HDAC7
PROTAC
Selectivity
Hematologic malignancies
Non-enzymatic function
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response
期刊论文
OAI收割
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 卷号: 14, 期号: 1, 页码: 19
作者:
Yao, Mingyue
;
Yan, Wenzhong
;
Wang, Yafang
;
Zhao, Yu
;
Xu, Xiaowei
  |  
收藏
  |  
浏览/下载:63/0
  |  
提交时间:2025/04/01
Acute myeloid leukemia
HDAC inhibitor
FLT3-ITD mutation
DNA damage response
Synergistic effect
Drug resistance
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired
N
-Linked 2-Acetylpyrrole Cap
期刊论文
OAI收割
MOLECULES, 2024, 卷号: 29, 期号: 19, 页码: 26
作者:
Zhang, Han
;
Shen, Qianqian
;
Hu, Zhu
;
Wu, Pei-Qian
;
Chen, Yi
  |  
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2024/11/26
HDAC inhibitors
anti-cancer activity
natural products
pyrrole derivatives
molecular docking
molecular dynamics simulation
NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe
期刊论文
OAI收割
EBIOMEDICINE, 2023, 卷号: 98, 页码: 18
作者:
Wang, Bo
;
Tang, Chu
;
Lin, En
;
Jia, Xiaohua
;
Xie, Ganyuan
  |  
收藏
  |  
浏览/下载:80/0
  |  
提交时间:2024/02/22
Hepatocellular carcinoma
Second near-infrared window
Molecular imaging
HDAC6
Fluorescence guided surgery
The intrinsic effects of using rhenium gaskets in hydrothermal diamond anvil cell experiments on background fluorescence, contamination, and redox control
期刊论文
OAI收割
CHEMICAL GEOLOGY, CHEMICAL GEOLOGY, 2023, 2023, 卷号: 632, 632, 页码: 14, 14
作者:
Cheng, Nanfei
;
Chou, I. -Ming
;
Wan, Ye
;
Wang, Ruoheng
;
Zhang, Haiyan
  |  
收藏
  |  
浏览/下载:64/0
  |  
提交时间:2023/10/07
HDAC
HDAC
Rhenium gasket
Raman spectroscopy
Background fluorescence
Contamination
Oxygen fugacity
Rhenium gasket
Raman spectroscopy
Background fluorescence
Contamination
Oxygen fugacity
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612
作者:
Wang, Xiaomin
;
Xu, Jun
;
Sun, Yiming
;
Cao, Siyuwei
;
Zeng, Hanlin
  |  
收藏
  |  
浏览/下载:91/0
  |  
提交时间:2023/10/17
HDAC inhibitors
Drug resistance
Histone methylation
Histone acetylation
Epigenetic interplay
Hedgehog pathway
ZIC1
LIFR
Combination therapy
Breast cancer
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKK? and overcomes gefitinib resistance in non-small cell lung cancer
期刊论文
OAI收割
CANCER BIOLOGY & MEDICINE, 2022, 卷号: 19, 期号: 8, 页码: 1172-1192
作者:
He, Ting
;
Gao, Yinglei
;
Fang, Yanfen
;
Zhang, Yangming
;
Zhang, Shuwei
  |  
收藏
  |  
浏览/下载:69/0
  |  
提交时间:2024/03/21
HDAC inhibitor
c-Met
IKK?
NSCLC
gefitinib
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
期刊论文
OAI收割
BIOCHEMICAL PHARMACOLOGY, 2022, 卷号: 201, 页码: 115070
作者:
Li, Yin-Ru
;
Liu, Fang-Fang
;
Liu, Wen-Bo
;
Zhang, Yi-Fan
;
Tian, Xin-Yi
  |  
收藏
  |  
浏览/下载:63/0
  |  
提交时间:2024/03/21
Epigenetic regulation
Tubulin
HDAC
Anticancer activity